Clinical application of midtrimester non-invasive fetal RHD genotyping and identification of RHD variants in a mixed-ethnic population

Prenatal Diagnosis

Volumn 33, Issue 2, 2013, Pages 173-178

  Grande, M ^a   Ordonez E ^b   Cirigliano, V ^b   Cid, J ^c   Grau, E ^c   Pericot, A ^a   Teixido, I ^a   Marin, J L ^d   Borrell, A ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b SYNLAB ACADEMY   (Germany)

^c Institut Catala de Salut   (Spain)

^d Centre de Diagnostic Biomedic   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

RHESUS D ANTIBODY;

ADULT; ARTICLE; CAUCASIAN; CLINICAL ASSESSMENT; DIAGNOSTIC ACCURACY; ETHNIC GROUP; EXON; FALSE NEGATIVE RESULT; FEMALE; GENE AMPLIFICATION; GENETIC COUNSELING; GENETIC IDENTIFICATION; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; PAKISTAN; PREDICTIVE VALUE; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REAL TIME POLYMERASE CHAIN REACTION; SECOND TRIMESTER PREGNANCY; SENSITIVITY ANALYSIS; SEROTYPING; SPAIN; ZYGOSITY;

CONTINENTAL POPULATION GROUPS; EXONS; FEMALE; FETAL BLOOD; GENOTYPING TECHNIQUES; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; RH-HR BLOOD-GROUP SYSTEM; SPAIN;

EID: 84873261757     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4035     Document Type: Article

References (29)

1. Moise KJ Jr. Management of rhesus alloimmunization in pregnancy. Obstet Gynecol 2008;112:164-76. Review.
2. Routine antenatal anti-D prophylaxis for women who are rhesus D negative. Review of NICE technology appraisal guidance 41. National Institute for Clinical Excellence.
3. Wagner FF, Flegel WA. RHD gene deletion occurred in the Rhesus box. Blood 2000;95:3662-8.
4. Colin Y, Chérif-Zahar B, Le Van Kim C, et al. Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood 1991;78:2747-52.
5. Singleton BK, Green CA, Avent ND, et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 2000;95:12-8.
6. Faas BH, Beckers EA, Wildoer P, et al. Molecular background of VS and weak C expression in blacks. Transfusion 1997;37:38-44.
7. Daniels GL, Faas BH, Green CA, et al. The VS and V blood group polymorphisms in Africans: a serologic and molecular analysis. Transfusion 1998;38:951-8.
8. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-7.
9. Lo YM, Hjelm NM, Fidler C, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:1734-8.
10. Faas BH, Beuling EA, Christiaens GC, et al. Detection of fetal RHD-specific sequences in maternal plasma. Lancet 1998;352:1196.
11. Finning KM, Martin PG, Soothill PW, Avent ND. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 2002;42:1079-85.
12. Müller SP, Bartels I, Stein W, et al. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Transfusion 2008;48:2292-301.
13. Rouillac-Le Sciellour C, Sérazin V, Brossard Y, et al. Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD. Transfus Clin Biol 2007;14:572-7.
14. Minon JM, Gerard C, Senterre JM, et al. Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium. Transfusion 2008;48:373-81.
15. Costa JM, Giovangrandi Y, Ernault P, et al. Fetal RHD genotyping in maternal serum during the first trimester of pregnancy. Br J Haematol 2002;119:255-60.
16. Geifman-Holtzman O, Grotegut CA, Gaughan JP. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood-a meta-analysis. Am J Obstet Gynecol 2006;195:1163-73.
17. Finning K, Martin P, Summers J, et al. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 2008;336:816-8.
18. Akolekar R, Finning K, Kuppusamy R, et al. Fetal RHD genotyping in maternal plasma at 11-13 weeks of gestation. Fetal Diagn Ther 2011;29:301-6.
19. Wikman AT, Tiblad E, Karlsson A, et al. Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy. Obstet Gynecol 2012;120:227-34.
20. Bombard AT, Akolekar R, Farkas DH, et al. Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women. Prenat Diagn 2011;31:802-8.
21. Lo YMD, Tein MSC, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-75.
22. Akolekar R, Farkas DH, VanAgtmael AL, et al. Fetal sex determination using circulating cell-free fetal DNA (ccffDNA) at 11 to 13 weeks of gestation. Prenat Diagn 2010;30:918-23.
23. Chan KC, Ding C, Gerovassili A, et al. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 2006;52:2211-8.
24. Tynan JA, Mahboubi P, Cagasan LL, et al. Restriction enzyme-mediated enhanced detection of circulating cell-free fetal DNA in maternal plasma. J Mol Diagn 2011;13:382-9.
25. Amaral DR, Credidio DC, Pellegrino J Jr, Castilho L. Fetal RHD genotyping by analysis of maternal plasma in a mixed population. J Clin Lab Anal 2011;25:100-4.
26. Esteban R, Montero R, Flegel WA, et al. The D category VI type 4 allele is prevalent in the Spanish population. Transfusion 2006;46:616-23.
27. Rouillac-Le Sciellour C, Puillandre P, Gillot R, et al. Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women. Mol Diagn 2004;8:23-31.
28. Wagner FF, Frohmajer A, Flegel WA. RHD positive haplotypes in D negative Europeans. BMC Genet 2001;2:10.
29. Queenan JT. Rh immunoprophylaxis and fetal RHD genotyping: where are we going? Obstet Gynecol 2012;120:219-20.